10-Q: Henry Schein Reports Strong Q2 2026 Results

Henry Schein, Inc. announced its Q2 2026 financial results, showcasing a 6.7% increase in net sales and improved profitability, driven by growth across its key segments.

Summary

• Henry Schein, Inc. reported net sales of $3,458 million for the three months ended June 27, 2026, a 6.7% increase compared to the same period in the prior year.
• Gross profit increased by 8.3% to $1,101 million, with a gross margin of 31.8%.
• Operating income rose to $171 million, up from $151 million in the prior year's quarter.
• Net income attributable to Henry Schein, Inc. was $94 million, or $0.82 per diluted share.
• The company's Global Distribution and Value-Added Services segment saw a 6.6% increase in net sales, driven by merchandise and equipment sales.
• Global Specialty Products and Global Technology segments also reported sales increases of 8.7% and 8.2%, respectively.
• The company's cash and cash equivalents stood at $157 million as of June 27, 2026.
• Total debt increased to $3,462 million, primarily due to higher bank credit lines and long-term debt.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as generally positive, reflecting solid revenue growth and improved profitability, though with some increases in operating expenses and debt.

Positives

• Net sales increased by 6.7% to $3,458 million for the quarter.
• Gross profit increased by 8.3% to $1,101 million, with a gross margin of 31.8%.
• Operating income improved by 13.2% to $171 million.
• Net income attributable to Henry Schein, Inc. increased to $94 million.
• Diluted earnings per share rose to $0.82 from $0.70 in the prior year's quarter.
• All three reportable segments (Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology) showed sales growth.
• The company's acquisition strategy continues to contribute to growth, with acquisitions adding 0.7% to total sales growth.
• Foreign exchange rates had a positive impact of 1.4% on total sales growth for the quarter.

Negatives

• Operating expenses increased by 7.5% to $930 million, driven by higher selling, general, and administrative costs and adjustments.
• Total debt increased to $3,462 million from $3,107 million, primarily due to higher bank credit lines and long-term debt.
• Accounts receivable days sales outstanding increased to 45.7 days from 44.7 days.
• Inventory turns decreased slightly to 4.6 from 4.7.
• Restructuring and related costs were $29 million for the quarter, impacting operating expenses.

Risks

• Dependence on third parties for product manufacturing and supply.
• Risks related to achieving strategic growth objectives and restructuring initiatives.
• Potential for cyberattacks or data security breaches.
• Highly competitive and consolidating market environment.
• Political, economic, and regulatory influences on the healthcare industry.
• Changes in laws and policies governing international trade and manufacturing.
• General global and domestic macroeconomic and political conditions, including inflation and geopolitical events.

Future Outlook

The company's acquisition strategy is focused on investments that add new customers, increase geographic footprint, and provide access to new products and technologies. The company believes its current liquidity and access to capital markets provide sufficient resources for its foreseeable capital needs.

Management Comments

• The company's BOLD+1 strategy focuses on investments in high growth, high margin businesses.
• The One Schein initiative aims to provide customers with streamlined access to a comprehensive offering of products and services.
• The healthcare industry's focus on cost containment benefits distributors capable of providing a broad array of products and services at low prices.
• The company is positioned to capitalize on industry consolidation by supporting increased sales through its existing infrastructure.

Industry Context

StockSavvy.ai notes that Henry Schein operates in the healthcare products distribution industry, which is experiencing trends such as industry consolidation, an aging population driving demand, and a focus on cost containment. The company's strategy aligns with these trends by pursuing acquisitions and offering a broad range of products and services.

Management Changes

Legal Proceedings

• None of the pending legal proceedings are currently anticipated to have a material adverse effect on the company's consolidated financial position, liquidity, or results of operations.

Related Party Transactions

• Royalty payments of $8 million and $16 million were recorded in selling, general and administrative expenses for the three and six months ended June 27, 2026, respectively, related to a joint venture with Internet Brands (Henry Schein One, LLC).
• Net payable balance to Internet Brands was $1 million as of June 27, 2026.
• Sales of $6 million and $14 million were recorded to equity method affiliates for the three and six months ended June 27, 2026, respectively.
• Purchases of $2 million and $4 million were made from equity method affiliates for the three and six months ended June 27, 2026, respectively.
• Related party operating lease liabilities were $5 million (current) and $19 million (non-current) as of June 27, 2026.

Stakeholder Impact

• Shareholders benefit from increased net sales, gross profit, and net income.
• Employees may be impacted by restructuring and related costs, but also by growth initiatives and potential incentive compensation.
• Customers benefit from the company's broad product and service offerings and its 'One Schein' initiative.
• Suppliers may see increased demand due to sales growth, but are also subject to the company's procurement practices.

Next Steps

• Continue integration of acquisitions aligned with the BOLD+1 strategy.
• Leverage the One Schein initiative to enhance customer access to products and services.
• Monitor and adapt to evolving industry trends, including cost containment and consolidation.
• Manage operating expenses and debt levels while pursuing growth opportunities.

Key Dates

Recommendation

The company demonstrates consistent growth in sales and profitability, supported by strategic acquisitions and a strong market position. However, the increase in debt and operating expenses, coupled with ongoing restructuring costs, warrants a cautious 'hold' rating until these factors are more fully resolved and their impact on future performance is clearer.

Keywords

Henry Schein, Quarterly Report, Form 10-Q, Financial Results, Healthcare Distribution, Dental Products, Medical Products, Specialty Products